ACUTE LEUKEMIA
Clinical trials for ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for blood cancer patients: experimental combo aims to stop transplant complications
Disease control CompletedThis study tested a new three-drug combination (PTCy, sirolimus, and VIC-1911) to prevent two major problems after a stem cell transplant: graft-versus-host disease (GVHD) and cancer relapse. It involved 16 adults with blood cancers like leukemia and lymphoma who received a high-…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope to tame dangerous side effect of Life-Saving transplants
Disease control CompletedThis study tested if a drug called palifermin, given before a stem cell transplant, could make the procedure safer and more effective. It involved 34 adults with blood cancers who received stem cells from an unrelated, matched donor. The main goals were to find a safe dose and se…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Beauty therapy tested to soothe fears of isolated cancer patients
Symptom relief CompletedThis study tested whether relaxing aesthetic care sessions could help patients feel better during difficult hospital stays. It involved 70 adults with acute leukemia or receiving a stem cell transplant, who had to stay in a protected isolation room for weeks. Researchers used que…
Matched conditions: ACUTE LEUKEMIA
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC
-
Scientists measure clotting factors in leukemia patients
Knowledge-focused CompletedThis completed study aimed to understand how blood clotting factors differ in people with acute leukemia. Researchers measured four specific clotting-related substances in 90 participants—60 with leukemia and 30 healthy people—to compare their levels. The goal was to gather knowl…
Matched conditions: ACUTE LEUKEMIA
Sponsor: Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
A multicenter, randomized, phase III registration trial of transplantation of NiCord®, ex vivo expanded, UCB-derived, stem and progenitor cells, vs. unmanipulated UCB for patients with hematological malignancies
CompletedThis study is an open-label, controlled, multicenter, international, Phase III, randomized study of transplantation of NiCord® versus transplantation of one or two unmanipulated, unrelated cord blood units in patients with acute lymphoblastic leukemia or acute myeloid leukemia, m…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE3 • Sponsor: Gamida Cell ltd
Last updated Mar 02, 2026 15:25 UTC